Moreover we found point mutations in TP53, IDH2, KRAS and NRAS further underpinning a genetic relation between BPDCN and myeloid malignancies, including acute myeloid leukemia and myelodysplastic syndrome. This evidence concerns the gene NRAS and acute myeloid leukemia.